This monthly feature focuses on various tranches and rounds of funding for healthcare ventures, startups and funds. Links indicate target companies and lead investors.
Target | Investors | Amount | Date |
---|---|---|---|
Milestone Pharmaceuticals Montreal Canada, Inc. | Novo Holdings A/S, Forbion Capital Partners, Tekla Capital Management, Domain Associates, Fonds de solidarite FTQ, BDC Capital, Pappas Capital and GO Capital | $55 million Series C | August 1, 2017 |
Homology Medicines, Inc. | Deerfield Management, Fidelity Management, HBM Healthcare Investments, Maverick Ventures, Novartis, Rock Springs Capital, Vida Ventures, Vivo Capital and Alexandria Venture Investments. Also, 5AM Ventures, ARCH Venture Partners and Temasek. | $83.5 million Series B | August 1, 2017 |
easyScripts | Bluff Point Associates | $2 million Series A | August 2, 2017 |
Amplyx Pharmaceuticals | Sofinnova Venture Partners, Lundbeckfonden Ventures, Arix Bioscience, Pappas Capital, New Enterprise Associates, RiverVest Venture Partners, 3x5 RiverVest II and BioMed Ventures | $67 million Series C | August 2, 2017 |
Fruit Street Health | Physician investors | $3 million equity investment | August 2, 2017 |
Buoy Health | F-Prime Capital Partners and FundRx | $6.7 million Series A | August 9, 2017 |
Happify Health | TT Capital Partners | $9 million | August 15, 2017 |
HealthJoy | Chicago Ventures, Social Capital, SidekickFun and GoHealth | $3 million Series A | August 15, 2017 |
Artemis Health | F-Prime Capital, Maverick Ventures and Kickstart Seed Fund | $16 million Series B | August 16, 2017 |
Stride Health | F-Prime Capital Partners, Venrock and New Enterprise Associats, as well as Portag3 Ventures | $23.5 million Series B | August 22, 2017 |
GNS Healthcare | Amgen Ventures | $6 million equity investment | August 23, 2017 |
Freenome | Section 32 | $7 million add-on Series A | August 28, 2017 |
Medgenome | Sequoia India and Sofina, with Zodius Capital, Kris Gopalakrishnan and Lakshmi Narayanan | $30 million Series C | August 28, 2017 |
SetPoint Medical | New Enterprise Associates, Morgenthaler, Medtronic, Boston Scientific, Topspin and Action Potential Venture Capital | $30 million Series D | August 28, 2017 |